Changjiang Pharmaceutical Group (300391.SZ) released its semi-annual report for 2024, with the company's revenue at 7365....
Zhìtōng Cáijīng APP News, Changjiang Pharmaceutical Group (300391.SZ) released its semi-annual report for 2024, with the company's revenue at 73.6537 million yuan, a year-on-year decrease of 84.53%. The net loss attributable to the shareholders of the listed company was 0.153 billion yuan, a year-on-year increase of 530.08%. The net loss attributable to the shareholders of the listed company, excluding non-recurring gains and losses, was 0.15 billion yuan, a year-on-year increase of 51.42%. The basic loss per share is 0.4355 yuan.
Comment(0)
Reason For Report